Dominick Frank Difabio, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 100 N Broadway, Irvington, NY 10533 Phone: 914-591-7300 Fax: 914-591-4080 |
Dr. Venkatesh Tulasuppa Sawkar, M.D Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 45 Pine Ln, Irvington, NY 10533 Phone: 914-591-8444 |
Dr. Heather Goodman, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1 Bridge St Ste 24, Irvington, NY 10533 Phone: 914-350-4788 Fax: 914-218-6558 |
Dr. Sally Hahn, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 100 N Broadway, Abbott House, Irvington, NY 10533 Phone: 914-591-7300 Fax: 914-591-4080 |
News Archive
Researchers of the Pharmacy and Mathematics departments of the CEU UCH university in Valencia have collaborated in the design of two artificial intelligence algorithms that improve the screening of positive cases in the early detection of cognitive impairment in chemists.
It appears that warnings regarding dangers of smoking appear to be having an effect with the UK placed in 22nd position in a world league of highest cancer rates. Figures show that for men, 280 cases per 100,000 people, is 33rd in the world, with France the highest. The rate for British women, however, is 260.5 per 100,000 – the world's 12th highest, with Denmark top. The UK breast cancer rate for women, which is just over 89, ranks 11th.
Most children who undergo screening to detect gluten intolerance, celiac disease, can handle it well. However, many people feel that the discovery of the disease and the treatment they receive does not provide a better quality of life.
Although tumor metastasis causes about 90 percent of cancer deaths, the exact mechanism that allows cancer cells to spread from one part of the body to another is not well understood. One key question is how tumor cells detach from the structural elements that normally hold tissues in place, then reattach themselves in a new site.
In the study, published in a recent issue of the journal Neurosurgery, 50 percent of stroke patients had little or no neurological disability one to three months after clot-dissolving medication was delivered directly to the site of the blockages, compared to 39 percent of patients with similarly good outcomes documented in a large national trial of intravenous (IV) drug treatment for stroke.
› Verified 9 days ago